Authors: Yu Ding, Dong Xing, Yiyan Fei, Boxun Lu
Published: 2022-10-11
DOI: 10.1039/d2cs00624c
Source: Full article
ATTECs and several other emerging degrader technologies hijacking the lysosomal pathways greatly expand the spectrum of degradable targets and provide new opportunities for targeted drug discovery.